Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million…
First U.S. patients being treated with Lenmeldy™ (atidarsagene autotemcel) in a commercial setting; other launch efforts progressing well following Food…
Milestone payment triggered by the initiation of a Phase 2 clinical trial in Alzheimer’s disease with MK-1167, an α7 nicotinic…
Bioxodes raises €2.7 million from existing investors in Series A extensionInterim data from BIRCH intracerebral hemorrhage (ICH) Phase 2a trial…
BRAINTREE, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously…
STAMFORD, Conn., Feb. 11, 2025 /PRNewswire/ -- Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation technologies and…
New certifications follow Dräger's previous ATO certification for a critical care ventilator Dräger Evita V800/V600 and Babylog VN800 family of…
Investment Powers the Debut of Pyxa: A Groundbreaking Platform for 3D Spatial Biology Research BOSTON, Feb. 11, 2025 /PRNewswire/ -- Stellaromics,…
Collaboration Aims to Develop First Intranasal Therapy for Mild Traumatic Brain Injury Aka Concussion, Establishing a Comprehensive Test-to-Treat PlatformSARASOTA, Fla.…
SEATTLE and VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical…